G484S Amino Acid Substitution in Lanosterol 14-α Demethylase ( ERG11 ) Is Related to Fluconazole Resistance in a Recurrent Cryptococcus neoformans Clinical Isolate

National Committee for Clinical Laboratory Standards

Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736 · see citing works

CLUSTAL: a package for performing multiple sequence alignment on a microcomputer

Higgins, D. G., & Sharp, P. M. (1988) · Gene · doi:10.1016/0378-1119(88)90330-7 · Cited by 3,394 · see citing works

Amino Acid Substitutions in the Cytochrome P-450 Lanosterol 14α-Demethylase (CYP51A1) from Azole-Resistant Candida albicans Clinical Isolates Contribute to Resistance to Azole Antifungal Agents

Sanglard, D., Ischer, F., Koymans, L. M. H., & Billé, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.241 · Cited by 465 · see citing works

Persistence of initial infection in recurrent Cryptococcus neoformans meningitis

Spitzer, E. D., Spitzer, S. G., Freundlich, L. F., & Casadevall, A. (1993) · The Lancet · doi:10.1016/0140-6736(93)90354-j · Cited by 165 · see citing works

Identification and characterization of a <i>Cryptococcus neoformans</i> ATP binding cassette (ABC) transporter‐encoding gene, <i>CnAFR1</i>, involved in the resistance to fluconazole

Posteraro, B., Sanguinetti, M., Sanglard, D., La Sorda, M., Boccia, S., Romano, L., Morace, G., & Fadda, G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03281.x · Cited by 143 · see citing works

Increased Fluconazole Resistance of Cryptococcus neoformans Isolated from a Patient with AIDS and Recurrent Meningitis

Paugam, A., Dupouy‐Camet, J., Blanche, P., Gangneux, J., Tourte-Schaefer, C., & Sicard, D. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.5.975-a · Cited by 117 · see citing works

The G464S amino acid substitution in Candida albicans sterol 14α-demethylase causes fluconazole resistance in the clinic through reduced affinity

Kelly, S. L., Lamb, D. C., Loeffler, J., Einsele, H., & Kelly, D. E. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1136 · Cited by 116 · see citing works

Drug resistance in Cryptococcus neoformans

Perfect, J. R., & Cox, G. M. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0090 · Cited by 106 · see citing works

Multiple Resistant Phenotypes of Candida albicans Coexist during Episodes of Oropharyngeal Candidiasis in Human Immunodeficiency Virus-Infected Patients

Lopez-Ribot, J. L., McAtee, R. K., Perea, S. H., Kirkpatrick, W. R., Rinaldi, M. G., & Patterson, T. F. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1621 · Cited by 94 · see citing works

Fluconazole tolerance in clinical isolates of Cryptococcus neoformans

Venkateswarlu, K., Taylor, M., Manning, N. J., Rinaldi, M. G., & Kelly, S. L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.748 · Cited by 74 · see citing works

Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease

Friese, G., Discher, T., Füssle, R., Schmalreck, A., & Lohmeyer, J. (2001) · AIDS · doi:10.1097/00002030-200111230-00026 · Cited by 64 · see citing works

Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis

Martinez, M. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.3.515 · Cited by 58 · see citing works

Involvement of multiple Cryptococcus neoformans strains in a single episode of cryptococcosis and reinfection with novel strains in recurrent infection demonstrated by random amplification of polymorphic DNA and DNA fingerprinting

Casadevall, A., & Spitzer, E. D. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.6.1682-1683.1995 · Cited by 56 · see citing works

Influence of Shaking on Antifungal Susceptibility Testing of Cryptococcus neoformans : a Comparison of the NCCLS Standard M27A Medium, Buffered Yeast Nitrogen Base, and RPMI–2% Glucose

Rodrı́guez-Tudela, J. L., Martín-Díez, F., Cuenca‐Estrella, M., Rodero, L., Carpintero, Y., & Gorgojo, B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.400-404.2000 · Cited by 41 · see citing works

Multidermatomal Herpes Zoster in an AIDS Patient

Edelstein, H. E. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.5.975 · Cited by 22 · see citing works

Multidrug Resistance: An Emerging Crisis

Tanwar, J., Das, S., Fatima, Z., & Hameed, S. (2014) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2014/541340 · Cited by 665 · see citing works

Mechanisms of Antifungal Drug Resistance

Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647 · see citing works

Efflux-Mediated Antifungal Drug Resistance

Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., & Monk, B. C. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-08 · Cited by 608 · see citing works

Regulatory circuitry governing fungal development, drug resistance, and disease.

Shapiro, R. S., Robbins, N., & Cowen, L. E. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00045-10 · Cited by 576 · see citing works

Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis

Kwon-Chung, K. J., Fraser, J. A., Doering, T. L., Wang, Z. A., Janbon, G., Idnurm, A., & Bahn, Y.-S. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019760 · Cited by 531 · see citing works

Molecular Evolution of Antifungal Drug Resistance

Robbins, N., Caplan, T., & Cowen, L. E. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-030117-020345 · Cited by 441 · see citing works

Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis

Scorzoni, L., de Paula e Silva, A. C. A., Marcos, C. M., Assato, P. A., de Melo, W. C. M. A., de Oliveira, H. C., Costa-Orlandi, C. B., Mendes-Giannini, M. J. S., & Fusco-Almeida, A. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00036 · Cited by 418 · see citing works

Untitled work

(2014) · doi:10.1128/cmr.00126-13 · Cited by 437 · see citing works

Molecular mechanisms governing antifungal drug resistance

Lee, Y., Robbins, N., & Cowen, L. E. (2023) · npj Antimicrobials and Resistance · doi:10.1038/s44259-023-00007-2 · Cited by 304 · see citing works

Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.

Cowen, L. E., & Steinbach, W. J. (2008) · Eukaryotic Cell · doi:10.1128/ec.00041-08 · Cited by 285 · see citing works

Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation

Sanglard, D., Coste, A., & Ferrari, S. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00578.x · Cited by 285 · see citing works

Fungal cytochrome P450 sterol 14α-demethylase (CYP51) and azole resistance in plant and human pathogens

Becher, R., & Wirsel, S. G. R. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-012-4195-9 · Cited by 247 · see citing works

The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors

Zhang, J., Li, L., Lv, Q., Yan, L., Wang, Y., & Jiang, Y. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00691 · Cited by 249 · see citing works

Resistance to antifungals that target CYP51

Parker, J. E., Warrilow, A. G. S., Price, C. L., Mullins, J. G. L., Kelly, D. E., & Kelly, S. L. (2014) · Journal of Chemical Biology · doi:10.1007/s12154-014-0121-1 · Cited by 207 · see citing works

Cryptococcus neoformans, a global threat to human health

Zhao, Y., Ye, L., Zhao, F., Zhang, L., Lu, Z., Chu, T., Wang, S., Liu, Z., Sun, Y., Chen, M., et al. (2023) · Infectious Diseases of Poverty · doi:10.1186/s40249-023-01073-4 · Cited by 206 · see citing works

Heteroresistance to Fluconazole in <i>Cryptococcus neoformans</i> Is Intrinsic and Associated with Virulence

Sionov, E., Chang, Y. C., Garraffo, H. M., & Kwon-Chung, K. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00295-09 · Cited by 179 · see citing works

Update on Antifungal Drug Resistance

Perlin, D. S., Shor, E., & Zhao, Y. (2015) · Current Clinical Microbiology Reports · doi:10.1007/s40588-015-0015-1 · Cited by 174 · see citing works

Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis

Stone, N. R. H., Rhodes, J., Fisher, M. C., Mfinanga, S., Kivuyo, S., Rugemalila, J., Segal, E. S., Needleman, L., Molloy, S. F., Kwon-Chung, J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124516 · Cited by 167 · see citing works

A systematic review of fluconazole resistance in clinical isolates ofCryptococcusspecies

Bongomin, F., Oladele, R. O., Gago, S., Moore, C. B., & Richardson, M. D. (2018) · Mycoses · doi:10.1111/myc.12747 · Cited by 153 · see citing works

Combatting the evolution of antifungal resistance in Cryptococcus neoformans

Bermas, A., & Geddes‐McAlister, J. (2020) · Molecular Microbiology · doi:10.1111/mmi.14565 · Cited by 138 · see citing works

Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications

Forastiero, A., Mesa-Arango, A. C., Alastruey-Izquierdo, A., Alcazar-Fuoli, L., Bernal-Martinez, L., Pelaez, T., Lopez, J. F., Grimalt, J. O., Gomez-Lopez, A., Cuesta, I., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00477-13 · Cited by 131 · see citing works

Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment

Gullo, F. P., Rossi, S. A., Sardi, J. D. C. O., Teodoro, V. L. I., Mendes‐Giannini, M. J. S., & Fusco‐Almeida, A. M. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1915-8 · Cited by 122 · see citing works

Identification of a Cryptococcus neoformans Cytochrome P450 Lanosterol 14α-Demethylase (Erg11) Residue Critical for Differential Susceptibility between Fluconazole/Voriconazole and Itraconazole/Posaconazole

Sionov, E., Chang, Y. C., Garraffo, H. M., Dolan, M. A., Ghannoum, M. A., & Kwon-Chung, K. J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05502-11 · Cited by 120 · see citing works

Role of AFR1 , an ABC Transporter-Encoding Gene, in the In Vivo Response to Fluconazole and Virulence of Cryptococcus neoformans

Sanguinetti, M., Posteraro, B., Sorda, M. L., Torelli, R., Fiori, B., Santangelo, R., Delogu, G., & Fadda, G. (2006) · Infection and Immunity · doi:10.1128/iai.74.2.1352-1359.2006 · Cited by 115 · see citing works

Three-Dimensional Model of Lanosterol 14α-Demethylase from Cryptococcus neoformans : Active-Site Characterization and Insights into Azole Binding

Sheng, C., Miao, Z., Ji, H., Yao, J., Wang, W., Che, X., Dong, G., Lü, J., Guo, W. P., & Zhang, W. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01630-08 · Cited by 113 · see citing works

Azole heteroresistance in Cryptococcus neoformans: Emergence of resistant clones with chromosomal disomy in the mouse brain during fluconazole treatment

Sionov, E., Chang, Y. C., & Kwon-Chung, K. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00694-13 · Cited by 112 · see citing works

Drug Strategies Targeting CYP51 in Neglected Tropical Diseases

Choi, J. Y., Podust, L. M., & Roush, W. R. (2014) · Chemical Reviews · doi:10.1021/cr5003134 · Cited by 110 · see citing works

Fungal Drug Response and Antimicrobial Resistance

Osset-Trénor, P., Pascual‐Ahuir, A., & Proft, M. (2023) · Journal of Fungi · doi:10.3390/jof9050565 · Cited by 103 · see citing works

A Population Genomics Approach to Assessing the Genetic Basis of Within-Host Microevolution Underlying Recurrent Cryptococcal Meningitis Infection

Rhodes, J., Beale, M. A., Vanhove, M., Jarvis, J. N., Kannambath, S., Simpson, J. A., Ryan, A., Meintjes, G., Harrison, T. S., Fisher, M. C., et al. (2017) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.116.037499 · Cited by 100 · see citing works

Elucidating Drug Resistance in Human Fungal Pathogens

Xie, J. L., Polvi, E. J., Shekhar‐Guturja, T., & Cowen, L. E. (2014) · Future Microbiology · doi:10.2217/fmb.14.18 · Cited by 98 · see citing works

Genetic Dissection of Azole Resistance Mechanisms in <i>Candida albicans</i> and Their Validation in a Mouse Model of Disseminated Infection

MacCallum, D. M., Coste, A., Ischer, F., Jacobsen, M. D., Odds, F. C., & Sanglard, D. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01645-09 · Cited by 98 · see citing works

Resistance to Antifungal Drugs

Ben‐Ami, R., & Kontoyiannis, D. P. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.003 · Cited by 101 · see citing works

Facilitators of adaptation and antifungal resistance mechanisms in clinically relevant fungi

Hokken, M., Zwaan, B. J., Melchers, W. J. G., & Verweij, P. E. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103254 · Cited by 94 · see citing works

Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications

Rogers, T. R., Verweij, P. E., Castanheira, M., Dannaoui, E., White, P. L., Arendrup, M. C., Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST), Arendrup, M. C., Arikan-Akdagli, S., Barchiesi, F., et al. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac161 · Cited by 82 · see citing works

A titanic drug resistance threat in Cryptococcus neoformans

Zafar, H., Altamirano, S., Ballou, E. R., & Nielsen, K. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.11.001 · Cited by 76 · see citing works

The investigational drug VT-1129 is a highly potent inhibitor of cryptococcus species CYP51 but only weakly inhibits the human enzyme

Warrilow, A. G. S., Parker, J. E., Price, C. L., Nes, W. D., Garvey, E. P., Hoekstra, W. J., Schotzinger, R. J., Kelly, D. E., & Kelly, S. L. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00349-16 · Cited by 75 · see citing works

Fluconazole resistance in cryptococcal disease: emerging or intrinsic?

Cheong, J. W. S., & McCormack, J. (2012) · Medical Mycology · doi:10.3109/13693786.2012.715763 · Cited by 75 · see citing works

New Approaches for Cryptococcosis Treatment

Spadari, C. D. C., Wirth, F., Lopes, L. B., & Ishida, K. (2020) · Microorganisms · doi:10.3390/microorganisms8040613 · Cited by 73 · see citing works

A One Health approach to overcoming fungal disease and antifungal resistance

Woods, M., McAlister, J. A., & Geddes‐McAlister, J. (2023) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1610 · Cited by 68 · see citing works

Medically Important Fungi Respond to Azole Drugs: An Update

Zavřel, M., & White, T. C. (2015) · Future Microbiology · doi:10.2217/fmb.15.47 · Cited by 64 · see citing works

Roles of Three Cryptococcus neoformans and Cryptococcus gattii Efflux Pump-Coding Genes in Response to Drug Treatment

Chang, M., Sionov, E., Lamichhane, A. K., Kwon-Chung, K. J., & Chang, Y. C. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01751-17 · Cited by 63 · see citing works

Fungal sphingolipids: role in the regulation of virulence and potential as targets for future antifungal therapies

Fernandes, C. M., & Poeta, M. D. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1792288 · Cited by 59 · see citing works

Novel mutations in CYP51B from Penicillium digitatum involved in prochloraz resistance

Wang, J., Yu, J., Liu, J., Yuan, Y., Li, N., He, M., Qi, T., Hui, G., Xiong, L., & Liu, D. (2014) · The Journal of Microbiology · doi:10.1007/s12275-014-4112-2 · Cited by 59 · see citing works

Genetic basis of antifungal drug resistance

Marie, C. S., & White, T. C. (2009) · Current Fungal Infection Reports · doi:10.1007/s12281-009-0021-y · Cited by 59 · see citing works

Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans

Perkins, A., Gómez‐López, A., Mellado, E., Rodrı́guez-Tudela, J. L., & Cuenca‐Estrella, M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki393 · Cited by 58 · see citing works

Characterization of the chromosome 4 genes that affect fluconazole-induced disomy formation in Cryptococcus neoformans

Ngamskulrungroj, P., Chang, Y., Hansen, B., Bugge, C., Fischer, E., & Kwon-Chung, K. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033022 · Cited by 56 · see citing works

Resistance to Voriconazole Due to a G448S Substitution in Aspergillus fumigatus in a Patient with Cerebral Aspergillosis

Peláez, T., Gijón, P., Bunsow, E., Bouza, E., Sánchez-Yebra, W., Valerio, M., Gama, B., Cuenca‐Estrella, M., & Mellado, E. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00329-12 · Cited by 51 · see citing works

Emerging Issues in Antifungal Resistance

Perfect, J. R., & Ghannoum, M. A. (2020) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2020.05.003 · Cited by 44 · see citing works

A Cyp51B Mutation Contributes to Azole Resistance in Aspergillus fumigatus

González-Jiménez, I., Lucio, J., Amich, J., Cuesta, I., Arroyo, R. S., Alcázar‐Fuoli, L., & Mellado, E. (2020) · Journal of Fungi · doi:10.3390/jof6040315 · Cited by 47 · see citing works

Molecular typing and antifungal susceptibility of clinical sequential isolates of Cryptococcus neoformans from Sao Paulo State, Brazil

Fusco‐Almeida, A. M., Matsumoto, M. T., Baeza, L. C., Silva, R. B. D. O. E., Kleiner, A. A. P., Melhem, M. D. S. C., & Mendes‐Giannini, M. J. S. (2006) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2006.00128.x · Cited by 44 · see citing works

Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain

Gago, S., Serrano, C., Alastruey‐Izquierdo, A., Cuesta, I., Martín‐Mazuelos, E., Aller, A. I., Gómez‐López, A., & Mellado, E. (2016) · Mycoses · doi:10.1111/myc.12543 · Cited by 43 · see citing works

Emerging Mechanisms of Drug Resistance in Candida albicans

Prasad, R., Nair, R., & Banerjee, A. (2019) · Progress in molecular and subcellular biology · doi:10.1007/978-3-030-13035-0_6 · Cited by 43 · see citing works

Cryptococcus neoformans Yap1 is required for normal fluconazole and oxidative stress resistance

Paul, S. K., Doering, T. L., & Moye-Rowley, S. (2014) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2014.10.015 · Cited by 39 · see citing works

Cloning and characterization of the lanosterol 14α-demethylase (ERG11) gene in Cryptococcus neoformans

Revankar, S. G., Fu, J., Rinaldi, M. G., Kelly, S. L., Kelly, D. E., Lamb, D. C., Keller, S. M., & Wickes, B. L. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.112 · Cited by 39 · see citing works

Azole Resistance in Cryptococcus gattii from the Pacific Northwest: Investigation of the Role of ERG11

Gast, C. E., Júnior, L. R. B., Bruzual, I., & Wong, B. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02287-12 · Cited by 39 · see citing works

An Atypical ABC Transporter Is Involved in Antifungal Resistance and Host Interactions in the Pathogenic Fungus Cryptococcus neoformans

Winski, C. J., Qian, Y., Mobashery, S., & Santiago-Tirado, F. H. (2022) · mBio · doi:10.1128/mbio.01539-22 · Cited by 37 · see citing works

Resistance to antifungal therapies

Prasad, R., Banerjee, A., & Shah, A. H. (2017) · Essays in Biochemistry · doi:10.1042/ebc20160067 · Cited by 33 · see citing works

Triclosan Demonstrates Synergic Effect with Amphotericin B and Fluconazole and Induces Apoptosis-Like Cell Death in Cryptococcus neoformans

Movahed, E., Tan, G. M. Y., Munusamy, K., Yeow, T. C., Tay, S. T., Wong, W. F., & Looi, C. Y. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00360 · Cited by 30 · see citing works

Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017

Selb, R., Fuchs, V., Graf, B., Hamprecht, A. G., Hogardt, M., Sedlacek, L., Schwarz, R., Idelevich, E. A., Becker, S. L., Held, J., et al. (2019) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2019.151336 · Cited by 31 · see citing works

Shifting from Ammonium to Phosphonium Salts: A Promising Strategy to Develop Next-Generation Weapons against Biofilms

Alfei, S. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16010080 · Cited by 31 · see citing works

Amino acid substitution in Cryptococcus neoformans lanosterol 14-α-demethylase involved in fluconazole resistance in clinical isolates

Bosco‐Borgeat, M. E., Mazza, M., Taverna, C. G., Córdoba, S. B., Murisengo, O. A., Vivot, W., & Davel, G. (2016) · Revista Argentina de Microbiología · doi:10.1016/j.ram.2016.03.003 · Cited by 30 · see citing works

Analysis of Cyp51 protein sequences shows 4 major Cyp51 gene family groups across fungi

Celia-Sanchez, B. N., Mangum, B., Brewer, M. T., & Momany, M. (2022) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkac249 · Cited by 29 · see citing works

Coregulation of extracellular vesicle production and fluconazole susceptibility in Cryptococcus neoformans

Rizzo, J., Trottier, A., Moyrand, F., Coppée, J., Maufrais, C., Zimbres, A. C. G., Dang, T. T. V., Alanio, A., Desnos‐Ollivier, M., Mouyna, I., et al. (2023) · mBio · doi:10.1128/mbio.00870-23 · Cited by 29 · see citing works

Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates

Rossi, S. A., Trevijano‐Contador, N., Scorzoni, L., Mesa-Arango, A. C., de Oliveira, H. C., Werther, K., Raso, T. D. F., Mendes‐Giannini, M. J. S., Zaragoza, Ó., & Fusco‐Almeida, A. M. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00153 · Cited by 26 · see citing works

Antibiotic Resistance

Rai, M., Kon, K. V., Gade, A., Ingle, A. P., Nagaonkar, D., Paralikar, P., & da Silva, S. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803642-6.00006-x · Cited by 25 · see citing works

Multi-azole-resistant strains of Cryptococcus neoformans var. grubii isolated from a FLZ-resistant strain by culturing in medium containing voriconazole

Kano, R., Okubo, M., Hasegawa, A., & Kamata, H. (2017) · Medical Mycology · doi:10.1093/mmy/myw101 · Cited by 25 · see citing works

The Microevolution of Antifungal Drug Resistance in Pathogenic Fungi

Boyce, K. J. (2023) · Microorganisms · doi:10.3390/microorganisms11112757 · Cited by 25 · see citing works

Fluconazole Susceptibility in Cryptococcus gattii Is Dependent on the ABC Transporter Pdr11

Yang, M. L., Uhrig, J. P., Vu, K., Singapuri, A., Dennis, M., Gelli, A., & Thompson, G. R. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01777-15 · Cited by 24 · see citing works

Effects of sertraline hydrochloride and fluconazole combinations onCryptococcus neoformansandCryptococcus gattii

Nayak, R., & Xu, J. (2010) · Mycology&#58 An International Journal on Fungal Biology · doi:10.1080/21501203.2010.487054 · Cited by 23 · see citing works

Genome Sequencing of Cladobotryum protrusum Provides Insights into the Evolution and Pathogenic Mechanisms of the Cobweb Disease Pathogen on Cultivated Mushroom

Sossah, F. L., Liu, Z., Yang, C., Okorley, B. A., Sun, L., Fu, Y., & Li, Y. (2019) · Genes · doi:10.3390/genes10020124 · Cited by 23 · see citing works

Prevention and Eradication of Biofilm by Dendrimers: A Possibility Still Little Explored

Alfei, S., & Caviglia, D. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102016 · Cited by 22 · see citing works

Searching for new antifungals for the treatment of cryptococcosis

de Sousa, N. S. O., de Almeida, J. D. R., Frickmann, H., Lacerda, M., & de Souza, J. V. B. (2023) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0121-2023 · Cited by 21 · see citing works

Regulation of ERG3, ERG6, and ERG11 Genes in Antifungal-Resistant isolates of Candida parapsilosis

Lotfali, E., Ghajari, A., Kordbacheh, P., Zaini, F., Mirhendi, H., Mohammadi, R., Noorbakhsh, F., & Rezaie, S. (2017) · Iranian Biomedical Journal · doi:10.18869/acadpub.ibj.21.4.275 · Cited by 22 · see citing works

The Impact of Climate Change on Human Fungal Pathogen Distribution and Disease Incidence

Hamm, P. S., & Torres-Cruz, T. J. (2024) · Current Clinical Microbiology Reports · doi:10.1007/s40588-024-00224-x · Cited by 24 · see citing works

The Ins and Outs of Azole Antifungal Drug Resistance: Molecular Mechanisms of Transport

Zavřel, M., Esquivel, B. D., & White, T. C. (2017) · Springer eBooks · doi:10.1007/978-1-4939-0694-9_29 · Cited by 20 · see citing works

First Isolation of Azole-Resistant Cryptococcus neoformans from Feline Cryptococcosis

Kano, R., Okubo, M., Yanai, T., Hasegawa, A., & Kamata, H. (2015) · Mycopathologia · doi:10.1007/s11046-015-9919-9 · Cited by 19 · see citing works

Molecular Principles of Antifungal Drug Resistance

Sanglard, D., & White, T. C. (2014) · ASM Press eBooks · doi:10.1128/9781555815776.ch14 · Cited by 19 · see citing works

Brilacidin, a novel antifungal agent against Cryptococcus neoformans

Diehl, C., Pinzan, C. F., de Castro, P. A., Delbaje, E., García-Carnero, L. C., Sánchez‐León, E., Bhalla, K., Kronstad, J. W., Kim, D.-G., Doering, T. L., et al. (2024) · mBio · doi:10.1128/mbio.01031-24 · Cited by 18 · see citing works

Distribution and Diversity of Cytochrome P450 Monooxygenases in the Fungal Class Tremellomycetes

Akapo, O. O., Padayachee, T., Chen, W., Kappo, A. P., Yu, J., Nelson, D. R., & Syed, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122889 · Cited by 17 · see citing works

Molecular Epidemiology and Antifungal Resistance of Cryptococcus neoformans From Human Immunodeficiency Virus-Negative and Human Immunodeficiency Virus-Positive Patients in Eastern China

Zhou, Z., Zhu, C., Ip, M., Liu, M., Zhu, Z., Liu, R., Li, X., Zeng, L., & Wu, W. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.942940 · Cited by 15 · see citing works

Retrospective Study of Cryptococcal Meningitis With Elevated Minimum Inhibitory Concentration to Fluconazole in Immunocompromised Patients

Nasri, H., Kabbani, S., Alwan, M. B., Wang, Y. F., Rebolledo, P. A., Kraft, C. S., Nguyen, M. L., Anderson, A. M. L., & Rouphael, N. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw076 · Cited by 15 · see citing works

Experimental medical mycological research in Latin America - a 2000-2009 overview

San-Blas, G., & Burger, E. (2010) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2010.11.004 · Cited by 14 · see citing works

Experimental and in-host evolution of triazole resistance in human pathogenic fungi

Handelman, M., & Osherov, N. (2022) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2022.957577 · Cited by 14 · see citing works

Cryptococcus neoformansYop1, an endoplasmic reticulum curvature-stabilizing protein, participates with Sey1 in influencing fluconazole-induced disomy formation

Ngamskulrungroj, P., Chang, Y. C., Hansen, B. T., Bugge, C., Fischer, E. R., & Kwon-Chung, K. J. (2012) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2012.00824.x · Cited by 12 · see citing works

<i>In vivo</i>development of fluconazole resistance in serial<i>Cryptococcus gattii</i>isolates from a cat

Sykes, J. E., Hodge, G., Singapuri, A., Yang, M. L., Gelli, A., & Thompson, G. R. (2016) · Medical Mycology · doi:10.1093/mmy/myw104 · Cited by 13 · see citing works

Molecular mechanisms underlying the emergence of polygenetic antifungal drug resistance in msh2 mismatch repair mutants of Cryptococcus

Albehaijani, S. H. I., Macreadie, I. G., Morrissey, C. O., & Boyce, K. J. (2022) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlac033 · Cited by 13 · see citing works

Antifungal susceptibility and molecular characteristics of Cryptococcus spp. based on whole-genome sequencing in Zhejiang Province, China

Zhang, J., Wang, Z., Chen, Y., Zhou, Z., Yang, Q. H., Fu, Y., Zhao, F., Li, X., Chen, Q., Li, F., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.991703 · Cited by 11 · see citing works

Combating increased antifungal drug resistance in Cryptococcus, what should we do in the future?

Deng, H., Song, J., Huang, Y., Yang, C., Zang, X., Zhou, Y., Li, H., Dai, B., & Xue, X. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023011 · Cited by 11 · see citing works

Insights into the global emergence of antifungal drug resistance

Boyce, K. J., Morrissey, O., Idnurm, A., & Macreadie, I. G. (2019) · Microbiology Australia · doi:10.1071/ma19024 · Cited by 10 · see citing works

Reduced Susceptibility to Azoles in Cryptococcus gattii Correlates with the Substitution R258L in a Substrate Recognition Site of the Lanosterol 14-α-Demethylase

Carvajal, S. K., Melendres, J., Escandón, P., & Firacative, C. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01403-23 · Cited by 9 · see citing works

Disruption of the ATP-dependent unfoldase ClpX reverses antifungal resistance in Cryptococcus neoformans

Woods, M., Bermas, A., Ball, B., Muselius, B., Chan, N., Gutierrez‐Gongora, D., Ramezanpour, S. S., McAlister, J. A., Sieber, S. A., & Geddes‐McAlister, J. (2025) · Nature Communications · doi:10.1038/s41467-025-61412-x · Cited by 10 · see citing works

Lack of Association between Fluconazole Susceptibility and ERG11 Nucleotide Polymorphisms in Cryptococcus neoformans Clinical Isolates from Uganda

Atim, P. B., Meya, D. B., Gerlach, E. S., Muhanguzi, D., Male, A., Kanamwanji, B., & Nielsen, K. (2022) · Journal of Fungi · doi:10.3390/jof8050508 · Cited by 9 · see citing works

Cryptococcus neoformans: a Sugar-Coated Killer

Perfect, J. R. (2014) · ASM Press eBooks · doi:10.1128/9781555815776.ch21 · Cited by 9 · see citing works

Antifungal activity of Allamanda polyantha seed extract and its iridoids promote morphological alterations in Cryptococcus spp.

Bresciani, F. R., Santi, L., Beys‐da‐Silva, W. O., Berger, M., Barcellos, V. D. A., Schripsema, J., von Poser, G. L., Guimarães, J. A., & Vainstein, M. H. (2020) · Archiv der Pharmazie · doi:10.1002/ardp.202000133 · Cited by 8 · see citing works

Selection of Aspergillus fumigatus isolates carrying the G448S substitution in CYP51A gene after long-term treatment with voriconazole in an immunocompromised patient

Pontes, L., Beraquet, C. A. G., Arai, T., Watanabe, A., Moretti, M. L., & Schreiber, A. Z. (2022) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2022.02.002 · Cited by 8 · see citing works

Drug Resistance in Cryptococcus: Epidemiology and Molecular Mechanisms

Pfaller, M. A., Lodge, J. K., & Ghannoum, M. A. (2014) · ASM Press eBooks · doi:10.1128/9781555816858.ch16 · Cited by 9 · see citing works

African ST173 Cryptococcus deuterogattii strains are commonly less susceptible to fluconazole: An unclear mechanism of resistance

Bertout, S., Roger, F., Drakulovski, P., Martin, A. S., Gouveia, T., Kassi, F. K., Menan, H. I. E., Krasteva, D., Delaporte, É., & Bellet, V. (2019) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.10.017 · Cited by 8 · see citing works

A Comprehensive Analysis of the Lipidomic Signatures in Rhizopus delemar

Ali, B., Chauhan, A., Kumar, M., Kumar, P., Carolus, H., Romero, C. L., Vergauwen, R., Singh, A., Banerjee, A., Prakash, A., et al. (2024) · Journal of Fungi · doi:10.3390/jof10110760 · Cited by 7 · see citing works

Mechanisms of Resistance to Antifungal Agents

Perlin, D. S. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch130 · Cited by 7 · see citing works

Drug Resistance in Cryptococcus neoformans

Hanson, K. E., Alexander, B. D., & Perfect, J. R. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-595-8_20 · Cited by 7 · see citing works

Amino acid substitution in Cryptococcus neoformans lanosterol 14-α-demethylase involved in fluconazole resistance in clinical isolates

Bosco‐Borgeat, M. E., Mazza, M., Taverna, C. G., Córdoba, S. B., Murisengo, O. A., Vivot, W., & Davel, G. (2016) · Revista Argentina de Microbiología · doi:10.1016/j.ram.2016.03.003 · Cited by 30 · see citing works

Identification of a Cryptococcus neoformans Cytochrome P450 Lanosterol 14α-Demethylase (Erg11) Residue Critical for Differential Susceptibility between Fluconazole/Voriconazole and Itraconazole/Posaconazole

Sionov, E., Chang, Y. C., Garraffo, H. M., Dolan, M. A., Ghannoum, M. A., & Kwon-Chung, K. J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05502-11 · Cited by 120 · see citing works

Analyse de la sensibilité aux antifongiques des souches de Cryptococcus spp. provenant de Kinshasa (RDC), substitution intronique du gène ERG11 dans une des souches résistantes au fluconazole

Zono, B., Sacheli, R., Kabututu, P. Z., Bontems, S., Mvumbi, G. L., & HAYETTE, M.-P. (2022) · Open Repository and Bibliography (University of Liège)

S8.5d Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Colombia develop heteroresistance to fluconazole at high concentrations

Melendres, J., Carvajal, S. K., Escandón, P., & Firacative, C. (2022) · Medical Mycology · doi:10.1093/mmy/myac072.s8.5d · Cited by 2 · see citing works

First Isolation of Azole-Resistant Cryptococcus neoformans from Feline Cryptococcosis

Kano, R., Okubo, M., Yanai, T., Hasegawa, A., & Kamata, H. (2015) · Mycopathologia · doi:10.1007/s11046-015-9919-9 · Cited by 19 · see citing works